Verdelis Investments is pleased to announce the addition of Confluence Genetics to its growing portfolio of ag-tech investments.
Since 2012, Confluence Genetics has led the pace of innovation in soy quality traits, spurring industry-transforming change to meet the demand for more nutritious, sustainable, and energy-dense feed, food, and fuel. By leveraging advanced technology and proprietary soybean genetics, the company is committed to creating high-quality, nutrient-dense seed innovations that benefit everyone in the agribusiness value chain.
“We’re very pleased to welcome Confluence Genetics to the Verdelis portfolio,” said Bob Trogele, PhD, CEO of Verdelis Investments. “Their competitive advantage lies in a comprehensive technology core that includes proprietary genetics as well as their CropOS® technology platform and Crop Accelerator rapid prototyping facility. Their sole focus on quality traits in soybeans, combined with AI-powered seed advancements and speed breeding, gives them the capability to dramatically impact end markets. This makes them a good choice for plant genetics investments.”
Media Contact:
James C. Sulecki, Communications, Verdelis Investments | comm@verdelisinvestments.com